Nutranomics (NNRX) 10-K 13 Nov 14 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Jul. 31, 2014	Nov. 07, 2014	Jan. 31, 2014
Document And Entity Information [Abstract]	'	'	'
Entity Registrant Name	'NUTRANOMICS, INC.	'	'
Entity Central Index Key	'0001451433	'	'
Trading Symbol	'nnrx	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Current Fiscal Year End Date	'--07-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Common Stock, Shares Outstanding	'	54,023,354	'
Entity Public Float	'	'	$10,038,390
Document Type	'10-K	'	'
Document Period End Date	31-Jul-14	'	'
Amendment Flag	'false	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jul. 31, 2014	Jul. 31, 2013
CURRENT ASSETS	'	'
Cash and cash equivalents	$79,235	$11,129
Accounts receivable, net of allowance	152,879	159,107
Related party receivable	'	1,750
Prepaid expenses	4,516	1,674
Other current assets	23,254	'
Inventory	271,941	276,477
Total Current Assets	531,825	450,137
PROPERTY & EQUIPMENT, net	16,355	22,336
OTHER ASSETS	'	'
Rent deposit	2,000	2,000
Total Assets	550,180	474,473
CURRENT LIABILITIES	'	'
Accounts payable and accrued expenses	518,890	343,496
Lines of credit	33,098	261,911
Convertible notes payable-current portion	58,999	'
Loan payable-current portion	51,071	'
Note Derivative Liability	177,907	'
Related party payable	21,083	24,514
Related party notes payable	36,608	'
Unearned revenue	338,263	58,418
Total Current Liabilities	1,235,919	688,339
LONG-TERM LIABILITIES	'	'
Convertible notes payable	525,000	'
Loan payable	157,830	'
Related party notes payable	'	75,000
Total Liabilities	1,918,749	763,339
STOCKHOLDERS' DEFICIT	'	'
Common stock; par value of $.001, 750,000,000 shares authorized; 51,151,766 and 25,005,544 shares issued and outstanding at July 31, 2014 and July 31, 2013, respectively	51,153	25,006
Additional paid in capital	3,337,911	2,271,519
Accumulated deficit	-4,757,633	-2,585,391
Total Stockholders' Deficit	-1,368,569	-288,866
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$550,180	$474,473

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Statement of Financial Position [Abstract]	'	'
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	51,151,766	25,005,544
Common stock, shares outstanding	51,151,766	25,005,544

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Income Statement [Abstract]	'	'
REVENUES	$2,402,769	$2,858,200
COST OF SALES	1,655,580	2,211,702
Gross profit	747,189	646,498
OPERATING EXPENSES	'	'
General and administrative	640,231	301,238
Advertising and marketing	156,708	50,284
Professional fees	925,890	19,994
Research and development	32,233	44,706
Salaries and wages	909,566	385,075
Total Operating Expenses	2,664,628	801,297
OPERATING (LOSS)	-1,917,439	-154,799
OTHER INCOME (EXPENSE)	'	'
Loss on settlement of fraudulent activity	-37,664	'
Change in Fair Value of Derivative	14,458	'
Interest expense	-231,597	-16,652
Total Other Income (Expense)	-254,803	-16,652
NET (LOSS) BEFORE INCOME TAXES	-2,172,242	-171,451
Provision for income taxes	'	'
NET (LOSS)	($2,172,242)	($171,451)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share)	($0.05)	($0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	'	'
Weighted Average Shares Outstanding - Basic and Diluted (in shares)	45,587,928	24,993,967

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Deficit (USD $)	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Jul. 31, 2012	$24,978	$2,266,547	($2,413,940)	($122,415)
Balance (in shares) at Jul. 31, 2012	24,977,744	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'
Common stock issued for services	28	4,972	'	5,000
Common stock issued for services (in shares)	27,800	'	'	'
Net loss	'	'	-171,451	-171,451
Balance at Jul. 31, 2013	25,006	2,271,519	-2,585,391	-288,866
Balance (in shares) at Jul. 31, 2013	25,005,544	'	'	25,005,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'
Common stock issued for merger	21,500	-20,100	'	1,400
Common stock issued for merger (in shares)	21,500,000	'	'	'
Common stock issued for cash	1,500	91,912	'	93,412
Common stock issued for cash (in shares)	1,500,000	'	'	'
Common stock issued for services	2,430	805,422	'	807,852
Common stock issued for services (in shares)	2,429,555	'	'	'
Common stock issued for prepaid services	717	189,158	'	189,875
Common stock issued for prepaid services (in shares)	716,667	'	'	'
Net loss	'	'	-2,172,242	-2,172,242
Balance at Jul. 31, 2014	$51,153	$3,337,911	($4,757,633)	($1,368,569)
Balance (in shares) at Jul. 31, 2014	51,151,766	'	'	51,151,766

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
OPERATING ACTIVITIES	'	'
Net (Loss)	($2,172,242)	($171,451)
Adjustments to reconcile net (loss) to net cash from operating activities:	'	'
Allowance for bad debt	-5,772	4,738
Loss on settlement of fraudulent activity	-37,664	'
Gain (loss) on derivative	14,458	'
Amortization of debt discount	47,396	'
Short-term loan issued for professional fees	50,000	'
Depreciation expense	7,442	8,319
Share based compensation-common stock	807,852	5,000
Changes in operating assets and liabilities:	'	'
Accounts receivable	49,664	-89,444
Other assets	163,779	-2,888
Inventory	4,536	116,259
Deferred revenue	279,845	10,919
Accounts payable and accrued expenses	157,346	126,858
Net Cash (Used in) From Operating Activities	-633,360	8,310
INVESTING ACTIVITIES	'	'
Purchase of equipment	-1,461	-1,662
Net Cash (Used in) Investing Activities	-1,461	-1,662
FINANCING ACTIVITIES	'	'
Proceeds from related party payable	'	16,208
Repayments of related party payable	-3,431	-7,381
Proceeds from convertible debt	719,500	'
Repayment of loan payable	-91,099	'
Proceeds from line of credit	26,000	257,290
Repayment of line of credit	-4,813	-67,944
Repayments of notes payable- related party	-36,642	-225,714
Sale of common stock	93,412	'
Net Cash (Used in) From Financing Activities	702,927	-27,541
Net Increase (Decrease) in Cash and Cash Equivalents	68,106	-20,893
Cash and Cash Equivalents, Beginning of Period	11,129	32,022
Cash and Cash Equivalents, End of Period	79,235	11,129
Cash paid during the period for:	'	'
Interest	12,205	6,448
Income Taxes	'	'
Non-cash Investing and Financing activities:	'	'
Debt discount	182,897	'
Stock issued for prepaid expenses	189,875	'
Stock issued for Intangible asset	$60,900	'

NATURE_OF_OPERATIONS

NATURE OF OPERATIONS	12 Months Ended
	Jul. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
NATURE OF OPERATIONS	'
	NOTE 1 – NATURE OF OPERATIONS
	Health Education Corporation d.b.a. NutraNomics, Inc., (the "Company") was incorporated under the laws of the State of Delaware on February 14, 1996 and later reincorporated under the laws of the State of Utah on January 5, 1998. The Company was originally organized to provide education services, books, cassette tapes and public presentations. The Company utilized several revenue generating tools in order to accomplish this goal including Live Blood Analysis, iridology, bone density screening and other self-help methods. In 1998, the Company changed its incorporation to the State of Utah, the primary place of business. In 2001, the Company created its own line of nutritional products that quickly became its leading revenue source. The Company filed for the d.b.a. of NutraNomics, Inc., in order to fully prepare and utilize the brand name for expansion. In retail outlets and to its clientele, the Company is known as NutraNomics, Inc. The Company sells its own brand of supplements in 16 countries direct to the public. The Company also performs research and development services and outsource manufacturing for third party entities. Beyond its sales in both the United States and Canada, the Company maintains sales representatives in Taiwan, Japan, Singapore, Philippines, Malaysia and South Korea. The Company maintains multiple different trademarks, trade names and patents.
	Merger
	On September 13, 2013, Buka Ventures, Inc., a Nevada corporation ("Buka") and Health Education Corporation dba. Nutranomics, Inc., a Utah corporation ("Nutranomics"), executed and delivered a Share Exchange Agreement (the "Share Agreement") and all required or necessary documentation to complete a merger (collectively, the "Transaction Documents"), whereby Buka became the parent company and Nutranomics became the wholly-owned subsidiary on the closing of the Share Agreement. Prior to the closing of this transaction and pursuant to a certain Share Exchange Agreement dated September 13, 2013, Buka canceled 25,000,000 of its 46,500,000 issued and outstanding common shares and simultaneously issued 25,005,544 shares of its common stock in exchange for 8,994,800 shares of Nutranomics common stock. The merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of Nutranomics, which was incorporated on January 5, 1998.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jul. 31, 2014
Accounting Policies [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the economic environment, which management believes to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.
	Accounting Basis
	The Company's financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States. The Company has elected a July 31 fiscal year end.
	Cash and Cash Equivalents
	Cash and cash equivalents include all cash balances and highly liquid investments with an original maturity of three months or less. As of July 31, 2014 and 2013, the Company's cash balances were within the FDIC insurance coverage limits.
	Revenue Recognition
	Our revenue is derived from the service revenue from Live Blood Analysis, sale of retail products, and revenue derived from educational services.
	The Company's revenue recognition policy is in accordance with the requirements of Accounting Standards Codification ("ASC") 605, Revenue Recognition, and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. In this case, revenues are recognized upon notification that customer receipt has occurred. The Company accrues an estimated amount for sales returns and allowances related to defective or returned products at the time of sale based on its ability to estimate sales returns and allowances using historical information. As of July 31, 2014 and 2013, the Company calculated the amount to be less than 1% of sales so no allowance was accrued in either year. Shipping and handling fees and related freight costs and supplies associated with shipping products to customers are included as a component of cost of sales. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue.
	The Company also recognizes revenues from the distribution of its product through trade partners. Related revenues consist of product costs, distribution fees, testing and labeling costs, as well as any associated administrative fees. The Company recognizes these revenues after the product has been shipped from the outsource manufacturer to the trade partner. The Company has contractual obligation to pay the outsource manufacturers, and as a principal in these arrangements the Company includes the total product price as revenue in accordance with applicable accounting guidance. The Company has separately negotiated contractual relationships with its trade partners, and under contracts with these trade partners the Company assumes the credit risk of product produced by the outsource manufacturer and dispensed to the trade partner.
	Unearned Revenues consist of cash received in advance for products to be delivered at a future date. The Company records the payments received as a liability until the products are delivered. The Company recorded unearned revenue of $338,263 and $58,418 as of July 31, 2014 and 2013, respectively.
	Cost of Sales
	The Company includes product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, insurance on inventory, production-related depreciation expense and product license agreement expense in cost of sales.
	Advertising Costs
	The Company classifies expenses for advertising as general and administrative expenses. The Company incurred advertising costs of $156,708 and $50,284 during the years ended July 31, 2014 and 2013, respectively.
	Accounts Receivable
	Receivables from the sale of goods and services are stated at net realizable value, do not bear interest and do not generally require collateral. The Company adjusts credit limits based upon payment history and the customer's current creditworthiness. The Company maintains an allowance for doubtful accounts based upon a variety of factors. The Company reviews all open accounts and provides specific reserves for customer collection issues when it believes the loss is probable, considering such factors as the length of time receivables are past due, the financial condition of the customer, and historical experience. The Company also records a reserve for all customers, excluding those that have been specifically reserved for, based upon evaluation of historical losses. The Company recorded an allowance for doubtful accounts of $106,617 and $112,389 as of July 31, 2014 and 2013, respectively.
	Inventories
	Inventories are stated at the lower of cost or market. The cost for inventories is determined using the first-in, first-out method on the weighted average basis. The cost includes all expenditures incurred in bringing the goods to the point of sale and putting them in a salable condition. In assessing the ultimate realization of inventories, the Company makes judgments as to future demand requirements compared to current or committed inventory levels. The Company estimates the demand requirements based on market conditions, forecasts prepared by its customers, sales contracts and orders in hand. In addition, the Company estimates net realizable value based on intended use, current market value and inventory aging analyses. The Company writes down inventories for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventories and their estimated market value based upon assumptions about future demand and market conditions. As of July 31 inventories consisted of the following:
		July 31,		July 31,
		2014		2013
	Raw materials	$	41,056	$	35,713
	Finished goods		230,885		240,764
	Subtotal		271,941		276,477
	Reserve for obsolescence		-		-
	Total	$	271,941	$	276,477
	Concentration of Credit Risk
	Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash, accounts receivable, accounts payable, lines of credit, and notes payable. Due to short-term maturities, the carrying amount of these instruments approximates fair value. Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company occasionally maintains amounts on deposit with a financial institution that are in excess of the federally insured limit of $250,000. The risk is managed by maintaining all deposits in high quality financial institutions. The Company had $0 of cash balances in excess of federally insured limits at July 31, 2014 and 2013.
	Property and Equipment
	Property and equipment are recorded at cost less accumulated depreciation. Depreciation and amortization are calculated using the straight-line method over the expected useful life of the asset, after the asset is placed in service. Assets recorded under leasehold improvements are amortized using the straight-line method over the lesser of their useful lives or the related lease term. The Company uses the following useful lives for its major classifications of property and equipment:
	Description	Useful Lives
	Furniture & Fixtures	7 years
	Office Furniture	5 years
	Equipment & Machinery	5-7 years
	Leasehold Improvements	15 years
	The Company periodically evaluates the carrying value of long-lived assets to be held and used in accordance with ASC Topic 360. ASC Topic 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the asset's carrying amount. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair market values are reduced for the cost of disposal. For the years ended July 31, 2014 and 2013, the Company recorded no impairment losses.
	Research and Development Costs
	The Company expenses the costs of the development of its nutritional products during the period incurred. The Company incurred research and development expenses of $32,233 and $44,706 during the years ended July 31, 2014 and 2013, respectively.
	Stock-Based Compensation
	The Company follows the provisions of ASC 718 which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. The Company uses the Black-Scholes option valuation model for determining the fair value of stock based compensation. Option pricing models require the input of highly subjective assumptions, including the expected price volatility. Changes in these assumptions can materially affect the fair value estimate.
	The Company records the stock-based compensation awards issued to non-employees and other external entities for goods and services at either the fair market value of the goods received or services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines pertaining to when the service is complete or a performance commitment date is reached, whichever is earlier.
	Income Taxes
	The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws expected to be in effect when the differences are expected to be settled or realized. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax assets are reviewed for recoverability, and the Company records a valuation allowance to reduce its deferred income tax assets when it is more likely than not that all or some portion of the deferred income tax assets will not be realized.
	The Company recognizes the effect of tax positions only if those positions are more likely than not of being sustained. Recognized tax positions are measured at the largest amount that is greater than 50 percent likely to be realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Estimated interest and penalties related to underpayment of income taxes are recorded as a component of the tax provision in the statement of operations.
	Loss per Share
	Basic loss per share ("EPS") is computed by dividing net loss (the numerator) by the weighted-average number of common shares outstanding for the period (the denominator). Diluted EPS is computed by dividing net loss by the weighted-average number of common shares and potential common shares outstanding (if dilutive) during each period. Potential common shares include common shares to be issued related to convertible debentures and stock pending issue under the ratchet provision.
	As the Company has incurred losses for the years ended July 31, 2014 and 2013, the potentially dilutive shares are anti-dilutive and are thus not added into the loss per share calculations.
	Significant Concentrations
	There is currently one customer that makes up 38% and 46% of total sales as of July 31, 2014 and 2013, respectively. The loss of this customer would have a material adverse effect on the Company's financial condition and results of operation. There are currently five and three vendors that make up 70% and 81% of total purchases as of July 31, 2014 and 2013, respectively.
	Sales Tax Collected From Customers
	As a part of the Company's normal course of business, sales taxes are collected from customers. Such taxes collected are remitted, in a timely manner, to the appropriate governmental tax authority on behalf of the customer. The Company's policy is to present revenue and costs, net of value added and sales taxes.
	Fair Value of Financial Instruments
	ASC 820, "Fair Value Measurements and Disclosures" requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 - Quoted prices in active markets for identical assets or liabilities;
	Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and
	Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.
	The carrying amounts of the Company's financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments.
	The Company's Level 2 financial liabilities consist of the derivative liability of the Company's convertible promissory notes issued to investors. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a multinomial lattice model which incorporates transaction details such as Company stock price, contractual terms, default provisions, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.
	Recent Accounting Pronouncements
	In August 2014, the FASB amended Accounting Standards Update (ASU) ASU 205-40, Presentation of Financial Statements – Going Concern an entity's management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). Although public companies are required to apply the new guidance to all reporting periods beginning on or after December 15, 2016 (all other entities in the following year), the Company has adopted the new standard.
	In September 2014, the FASB issued Accounting Standards Update (ASU) ASU 606 which superseded and replaced ASC 605-25, Revenue Recognition: Multiple-Element Arrangements, and most of ASC 985-605, Software: Revenue Recognition, which applies to all software and SaaS arrangements. Although public companies are required to apply the new guidance to all reporting periods beginning on or after December 15, 2016 (all other entities in the following year), the Company has not yet adopted the new standard.
	Going Concern
The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has generally had net losses after consideration of income taxes. Further, the Company has negative working capital and insufficient cash flows from operation as of July 31, 2014, and does not have the requisite liquidity to pay its current obligations. These factors, among others, raise substantial doubt about its ability to continue as a going concern. Management will seek to increase revenues and reduce costs, while raising capital through the sale of its stock. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

COMMITMENTS_CONTINGENCIES_AND_

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	12 Months Ended
	Jul. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	'
	NOTE 3 – COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS
	Management of the Company has conducted a diligent search and concluded that there were no commitments, contingencies, or legal matters pending at the balance sheet dates that have not been disclosed.

PROVISION_FOR_INCOME_TAXES

PROVISION FOR INCOME TAXES	12 Months Ended
	Jul. 31, 2014
Income Tax Disclosure [Abstract]	'
PROVISION FOR INCOME TAXES	'
	NOTE 4 – PROVISION FOR INCOME TAXES
	The provision for income taxes consists of the following:
		July 31,			July 31,
		2014			2013
	Federal income tax expense	$	-		$	-
	State income tax expense		-			-
	Less change in valuation allowance		-			-
	Net income tax expense	$	-		$	-
	A reconciliation of income taxes computed at the federal statutory rate of 34% for July 31, 2014 and 2013 is as follows:
		2014			2013
	Federal income taxes at 34%	$	(738,562	)	$	(58,328	)
	State income tax, net of federal benefit		(71,684	)		(5,661	)
	Change in net operating loss		-			18,385
	Tax effect on non-deductible expenses and credits		1,844			701
	Changes in valuation allowance		808,402			44,903
		$	-		$	-
	The tax effects of temporary differences which give rise to deferred tax assets and liabilities consists of the following:
		July 31,			July 31,
		2014			2013
	Deferred tax asset attributable to:
	Net operating loss carryover	$	1,027,802		$	242,339
	Allowance for doubtful accounts		39,768			42,914
	Depreciation		2,776			9,302
	Less, valuation allowance		(1,070,346	)		(294,555	)
	Net deferred tax asset	$	-		$	-
	Deferred tax liability attributable to:
	Depreciation	$	-		$	-
	Net deferred tax liabilities	$	-		$	-
	The Company sustained net operating losses in 2014 in the accompanying statements of operations. No deferred tax asset or income tax benefits are reflected in the financial statements for net deductible temporary differences or net operating loss carryforwards, because the likelihood of realization of the related tax benefits cannot be established. Accordingly, a valuation allowance has been recorded to reduce the net deferred tax asset to zero, and consequently there is no income tax provision or benefit presented for the fiscal years ended July 31, 2014 and 2013. The valuation allowance increased by $775,791 to $1,070,346 in 2014.
	As of July 31, 2014, the Company had net operating loss carryforwards for tax reporting purposes of approximately $2,812,000. These net operating loss carryforwards, if unused, begin to expire in 2023. As of July 31, 2014 and 2013, the Company has no liabilities for unrecognized tax benefits. The Company's policy is to recognize potential interest and penalties accrued related to unrecognized tax benefits within income tax expense. For the years ended July 31, 2014, and 2013, the Company did not recognize any interest or penalties in its statement of operations, nor did it have any interest or penalties accrued in its balance sheet at July 31, 2014 and 2013 relating to unrecognized tax benefits.
	The Company has not yet filed the federal income tax return in the U.S for the 2014 calendar year. The calendar tax years 2013, 2012 and 2011 remain open to examination for federal income tax purposes and by the other major taxing jurisdictions to which the Company is subject.

ADVANCES_ON_ROYALTIES

ADVANCES ON ROYALTIES	12 Months Ended
	Jul. 31, 2014
Advance Royalties [Abstract]	'
ADVANCES ON ROYALTIES	'
	NOTE 5 – ADVANCES ON ROYALTIES
	On November 18, 2013, the Company entered into a License Agreement (the "License Agreement") with Gennesar Nutraceuticals, LLC d/b/a Genesar Nutraceuticles, a Utah limited liability company ("Genesar"), in which the Company's CEO is a minority owner. Pursuant to the License Agreement, Genesar granted the Company a worldwide exclusive license to all rights relating to, and intellectual property regarding, GenEpic™, a dietary supplement.
	Upon execution of the License Agreement, Genesar is entitled to receive 100,000 restricted shares of the Company common stock valued at $60,900 based on the market price on the date of execution, which were issued on March 26, 2014, a royalty fee of $4/box of 30 sachets of GenEpic sold by the Company beginning after 4,000 boxes have been sold, and a payment of $200,000 for advances on royalty fees, due by December 1, 2013. The License Agreement has an initial term of 36 months, and will automatically renew for another 36-month term unless terminated by providing 90 days written notice to the other party prior to the end of the term. As of July 31, 2014, the Company had paid $140,000 of the $200,000 prepayment of royalty fees, which will be offset against future royalty fees incurred on products sold. Subsequent to July 31, 2014, the Company amended the agreement to (1) remove the clause triggering royalty payments to begin after 4,000 boxes have been sold, and instead beginning royalty payments on the 20th of each month following the end of each of the Company's fiscal quarters, (2) adding a minimum royalty payment of $25,000 per year, (3) adjust the royalty fee to $5/box of 30 sachets of GenEpic sold by the Company from $4/box, and (4) restructuring the advance of $140,000, to a one-time license payment, which would no longer be offset against future royalty fees incurred on products sold. As of July 31, 2014, the balance of $140,000 in advances on royalties has been expensed, and the Company had a remaining balance in advances on royalties of $0.

LEASES

LEASES	12 Months Ended
	Jul. 31, 2014
Leases [Abstract]	'
LEASES	'
	NOTE 6 – LEASES
	The Company leases a 3,000 square foot office in the Draper, Utah that serves as its principal executive offices. The lease expires on December 31, 2014. Pursuant to the lease, the rent for the fiscal years ended July 31, 2014 and 2013 totaled $50,115 and $46,140, respectively.
	The Company has three separate subleases for three rooms totaling 1,500 square feet of their Draper office space to three individuals on a month to month basis. The remaining two leases were terminated in September 2013 and October 2013. Pursuant to the sublease agreements, the monthly rent received for the fiscal years ended July 31, 2014 and 2013 totaled $1,850 and $12,500, respectively.
	The Company leased certain machinery and equipment in 2013 under an agreement that is classified as an operating lease. The lease expired on July 15, 2013 and is now leased on a month-to-month basis. Rent expense under the operating lease totaled $4,346 and $3,717 at July 31, 2014 and 2013, respectively.
	The future minimum lease payments required under the operating leases as of July 31, 2014 are as follows:
	Year Ended July 31,	Amount
	2015	$	16,875
	2016		-
	2017		-
	2018		-
	Thereafter		-
	Total lease obligations	$	16,875

EQUIPMENT

EQUIPMENT	12 Months Ended
	Jul. 31, 2014
Property, Plant and Equipment [Abstract]	'
EQUIPMENT	'
	NOTE 7 – EQUIPMENT
	Property and equipment consists of the following as of July 31, 2014 and 2013. Depreciation expense was $7,442 and $8,319 for the years ended July 31, 2014 and 2013, respectively.
		July 31,			July 31,
		2014			2013
	Furniture & Fixtures	$	11,860		$	11,860
	Office Furniture		28,932			28,932
	Equipment & Machinery		47,002			45,541
	Accumulated Depreciation		(71,439	)		(63,997	)
	Net Book Value	$	16,355		$	22,336

RELATED_PARTY_NOTES_PAYABLE

RELATED PARTY NOTES PAYABLE	12 Months Ended
	Jul. 31, 2014
Related Party Notes Payable [Abstract]	'
RELATED PARTY NOTES PAYABLE	'
	NOTE 8 – RELATED PARTY NOTES PAYABLE
	In January 2012, the Company entered into a two year, zero percent note with an 8% imputed interest rate with an officer, in the amount of $150,000. The note is due on December 31, 2014. The Company agreed to pay royalty payments in connection with sales of a certain product line. The Company paid royalty payments of $38,392 and $1,063 in the years ended July 31, 2014 and 2013, respectively.
	As of July 31, 2014 and 2013, the Company owed a total of $36,608 and $75,000 in principal in related party notes.

RELATED_PARTY_PAYABLE

RELATED PARTY PAYABLE	12 Months Ended
	Jul. 31, 2014
Related Party Transactions [Abstract]	'
RELATED PARTY PAYABLE	'
	NOTE 9 – RELATED PARTY PAYABLE
	Related party payables consist of payments made by a director through credit cards and use of a line of credit related used to pay expenses on behalf of the Company. During the years ended July 31, 2014 and 2013, the officer lent $0 and $16,208 and the Company made payments of $3,431 and $7,381, respectively. As of July 31, 2014 and 2013, the Company owed a total of $21,083 and $24,514 in related party payables.

LINES_OF_CREDIT_AND_LOAN_PAYAB

LINES OF CREDIT AND LOAN PAYABLE	12 Months Ended
	Jul. 31, 2014
Lines Of Credit And Loan Payable [Abstract]	'
LINES OF CREDIT AND LOAN PAYABLE	'
	NOTE 10 – LINES OF CREDIT AND LOAN PAYABLE
	The Company maintains a Line of Credit with Key Bank (the "Lender"). The Line of Credit was opened on August 28, 2012, with an available $250,000 to be drawn on for one year, not to exceed the principal amount ("draw period"). Once the draw period is completed, advances will no longer be permitted and the Company shall repay the principal and interest outstanding, over 5 years ("repayment period"). The repayment period begins August 28, 2013, after which a minimum monthly payment amount will be determined. The initial interest rate is 5.210%, and is variable. The variable interest rate is based on an independent index which is the "prime rate" as published each business day in the "Money Rates" column of the Wall Street Journal. Interest on the note is computed on a 365/365 simple interest basis, using 1.960% points over the index. The Lender executed a commercial security agreement. With this agreement, the Lender is entitled to a security interest in the Company's inventory, chattel paper, accounts receivable and general intangibles. In August 2013, the line of credit was converted into a note, and the Company is no longer able to borrow any additional funds. Under the new terms of the note, the note has a face value of $250,000 that matures on September 1, 2018, with an interest rate of prime plus 1.960%, and as of the date of the note, the interest rate was 5.21%. The note has minimum monthly payments of $4,745 which started on October 1, 2013. The balance outstanding on this note and line of credit as of July 31, 2014 and July 31, 2013 was $208,901 and $244,000, respectively. As of July 31, 2014, the Company has paid $41,099 in principal payments. The Lender allowed the Company to absorb a prior $50,000 note into this note, not affecting the repayment date. The Company did incur issuance costs of $4,037, which were expensed upon occurrence.
	On December 9, 2013, the Company issued a promissory note to Southridge as part of an equity purchase agreement (the "Equity Purchase Agreement") for $50,000, with 0% interest. The note was issued in lieu of due diligence and legal fees. This note matured and was paid in full on May 31, 2014. (see NOTE 12).
	Loans payable consisted of the following as of July 31, 2014 and July 31, 2013, respectively :
	Loan Payable
		July 31,			July 31,
		2014			2013
	$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.		$	208,901	$	-
	$50,000 face value, issued on December 9, 2013, with no interest rate, matured and was paid in full on May 31, 2014.			-		-
	Total Loan payable			208,901		-
	Less current portion			51,071		-
	Loan payable, long-term		$	157,830	$	-
	In 1998, the Company entered into a line of credit with Zions Bank ("Lender") with a credit limit of $40,000. The line bears a compounding per annum fixed interest rate of 5.25%. As of July 31, 2014 and July 31, 2013, the Company owed $33,098 and $17,911 in principal, respectively. The Lender executed a commercial security agreement. With this agreement, the Lender is entitled to a security interest in the Company's inventory, chattel paper, accounts receivable and general intangibles. The Company did incur a setup fee, which has been fully amortized. There is no term limit on the line and the Company is allowed to draw up to its dollar limit.

CONVERTIBLE_NOTES_PAYABLE_AND_

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE	12 Months Ended
	Jul. 31, 2014
Convertible Notes Payable And Loan Payable [Abstract]	'
CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE	'
	NOTE 11 – CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE
	Convertible notes payable consisted of the following as of July 31, 2014 and July 31, 2013, respectively:
		July 31,		July 31,
		2014		2013
	$250,000 face value, issued on September 27, 2013, interest rate of 10%, matures on September 27, 2015.	$	250,000	$	-
	$125,000 face value, issued on October 18, 2013, interest rate of 10%, matures on October 18, 2015.		125,000		-
	$150,000 face value, issued on November 22, 2013, interest rate of 10%, matures on November 22, 2015.		150,000		-
	$78,500 face value, issued on January 14, 2014, interest rate of 8%, matures on October 14, 2014, net of unamortized discount of $48,741 and $0 as of July 31, 2014 and July 31, 2013.		29,759		-
	$53,000 face value, issued on March 19, 2014, interest rate of 8%, matures on December 26, 2014, net of unamortized discount of $39,087 and $0 as of July 31, 2014 and July 31, 2013.		13,913		-
	$63,000 face value, issued on May 15, 2014, interest rate of 8%, matures on February 2, 2015, net of unamortized discount of $47,673 and $0 as of January 31, 2014 and July 31, 2013.		15,327		-
	Total convertible notes payable – non-related parties		583,999		-
	Less current portion		58,999		-
	Convertible notes payable, long-term	$	525,000	$	-
	On September 27, 2013, the Company issued a convertible note to an unrelated party for $250,000 that matures in September 27, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after September 27, 2013 in part or in whole into shares of the Company's Common Stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at maturity date.
	On October 18, 2013, the Company issued a convertible note to an unrelated party for $125,000 that matures in October 18, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after October 18, 2013 in part or in whole into shares of the Company's Common Stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at the maturity date.
	On November 22, 2013, the Company issued a convertible note to an unrelated party for $150,000 that matures in November 22, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after November 22, 2013 in part or in whole into shares of the Company's Common Stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at the maturity date.
	On January 14, 2014, the Company entered into a convertible promissory note with Asher Enterprises, Inc. ("Asher") a Delaware Corporation for an 8% convertible promissory note with an aggregate principal amount of $78,500 which together with any unpaid accrued interest is due on October 17, 2014. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the ten trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In January 2014, the Company received cash in the amount of $58,600, with the remaining $19,900 being used for legal and accounting fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On January 14, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $87,968 and a discount on the note of $78,500.
	On March 19, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. ("KBM") a New York Corporation for an 8% convertible promissory note with an aggregate principal amount of $53,000 which together with any unpaid accrued interest is due on December 26, 2014. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In March 2014, the Company received cash in the amount of $24,487, with the remaining $6,898 being used for legal and accounting fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On March 19, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $47,806 and a discount on the note of $49,010.
	On May 15, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. ("KBM") a New York Corporation for an 8% convertible promissory note with an aggregate principal amount of $63,000 which together with any unpaid accrued interest is due on February 2, 2015. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In May 2014, the Company received cash in the amount of $42,500, with the remaining $17,500 being used for legal fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On May 15, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $56,591 and a discount on the note of $56,591.
	As of July 31, 2014, the Company estimated the fair market value of the derivative liability to be $177,907, with a change in fair value of $14,458, and recorded $47,396 in amortization related to the discount on the note to interest expense. See note 13.

STOCK_TRANSACTIONS

STOCK TRANSACTIONS	12 Months Ended
	Jul. 31, 2014
Stockholders' Equity Note [Abstract]	'
STOCK TRANSACTIONS	'
	NOTE 12 – STOCK TRANSACTIONS
	As of July 31, 2014 and July 31, 2013, the Company has 750,000,000 shares of common stock authorized with a par value of $.001, and 51,151,766 and 25,005,544 shares of common stock issued and outstanding, respectively.
	During the year ended July 31, 2014, the Company also issued 2,429,555 shares of Common Stock as share-based compensation to employees and non-employees valued at $807,852, based on the market price of the stock as of the applicable measurement date. The Company also issued 1,500,000 shares of Common Stock as part of the Equity Purchase Agreement described in the following paragraphs for cash for $93,412. The Company also issued 716,667 shares of fully vested and nontransferable common stock as prepaid services over a six month period valued at $189,875 based on the market price as of the measurement date.
	Equity Purchase Agreement
	The Company entered into an equity purchase agreement with Southridge Partners II, LP ("Southridge") on December 9, 2013. Pursuant to the Equity Purchase Agreement, Southridge committed to purchase up to $10,000,000 of the Company's common stock, over a period of time terminating on the earlier of: (i) 24 months from the effective date of a registration statement to be filed in connection therewith or (ii) the date on which Southridge has purchased shares of common stock pursuant to this agreement for an aggregate maximum purchase price of $10,000,000; such commitment is subject to certain conditions. The purchase price to be paid by Southridge will be 90% of the average of the lowest three (3) daily volume weighted average prices for the Company's common stock for the ten (10) trading days immediately following clearing of the Estimated Put Shares (defined below) (such purchase price the "Put Purchase Price") under the Equity Purchase Agreement.
	The Company will deliver to Southridge, simultaneously with delivery of a Put Notice, a number of Shares equal to 125% of the Investment Amount divided by the closing price of the Company's common stock on the day preceding the Put Notice date (the "Estimated Put Shares"). The actual number of Shares purchased by Southridge for the Investment Amount shall then be calculated by dividing the Investment Amount by the Put Purchase Price. Any excess Estimated Put Shares shall then be returned to the Company.
	The number of Shares sold to Southridge at any time shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Also as part of the equity purchase agreement, the Company issued a promissory note to Southridge for $50,000, with 0% interest. This note matured on May 31, 2014, and was not convertible into common stock. Finally, as part of the equity purchase agreement, Southridge is prohibited from executing any short sales of the Company's common stock during the term of the equity purchase agreement.
	The Company will not be entitled to put shares to Southridge:
	·unless there is an effective registration statement under the Securities Act to cover the resale of the shares by Southridge;
	·unless the common stock continues to be quoted on the OTC Bulletin Board and has not been suspended from trading;
	·if an injunction shall have been issued and remain in force, or action commenced by a governmental authority which has not been stayed or abandoned, prohibiting the purchase or the issuance of the shares to Southridge;
	·if the Company has not complied with their obligations and are otherwise in breach of or in default under, the Equity Purchase Agreement, our registration rights agreement (the "Registration Rights Agreement") with Southridge or any other agreement executed in connection therewith with Southridge;
	·since the date of the filing of the Company's most recent filing with the Securities and Exchange Commission no event that had or is reasonably likely to have a Material Adverse Effect (as defined in the Equity Purchase Agreement) has occurred; and
	·to the extent that such shares would cause Southridge's beneficial ownership to exceed 9.99% of our outstanding shares.
	The Equity Purchase Agreement further provides that Southridge is entitled to customary indemnification from the Company for any losses or liabilities it suffers as a result of any breach of any provisions of the Equity Purchase Agreement or the Registration Rights Agreement, or as a result of any lawsuit brought by a third-party arising out of or resulting from Southridge's execution, delivery, performance or enforcement of the Equity Purchase Agreement or the Registration Rights Agreement or from material misstatements or omissions in the prospectus accompanying the registration statement for the resale of the shares issued to Southridge.
	The Company's registration statement with respect to 6,500,000 shares to be issued to Southridge under the Equity Purchase Agreement was declared effective by the SEC on May 5, 2014.  As of July 31, 2014, 1,500,000 registered shares have been issued to Southridge under the Equity Purchase Agreement.

DERIVATIVE_LIABILITY

DERIVATIVE LIABILITY	12 Months Ended
	Jul. 31, 2014
Derivative Liability [Abstract]	'
DERIVATIVE LIABILITY	'
	NOTE 13 – DERIVATIVE LIABILITY
	The Company has one liability measured at fair value on a recurring basis, which consists of a derivative liability on certain convertible notes payable (see NOTE 11). As of July 31, 2014 this derivative liability had an estimated fair value of $177,907. The Company has no assets that are measured at fair value on a recurring basis.
	The following table presents information about our derivative liability, which was our only financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs that are either directly or indirectly observable (Level 2) as of July 31, 2014:
	Balance at July 31, 2013		$	-
	New Derivative Liability			192,365
	Total (gains)losses included in earnings			(14,458	)
	Issuances			-
	Balance at July 31, 2014		$	177,907
	The fair value of this derivative liability was calculated using the multinomial lattice models that value the derivative liability within the notes based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion feature with the reset provisions; redemption provisions; and the default provisions. Assumptions used to calculate the fair value of the derivative liability were as follows:
		July 31,
		2014
	Expected term in years		.21-51 years
	Risk-free interest rates		0.05-0.12	%
	Volatility		121-.157	%
	Dividend yield		0	%
	In addition to the assumptions above, the Company also takes into consideration whether or not the Company would participate in another round of financing and if that financing is registered or not and what that stock price would be for the financing at that time. The Company will continue to adjust the derivative liability for changes in fair value until the notes matures on October 14, 2014, December 26, 2014, and February 2, 2015.

INDUSTRY_SEGMENT_GEOGRAPHIC_IN

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS	12 Months Ended
	Jul. 31, 2014
Segment Reporting [Abstract]	'
INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS	'
	NOTE 14 – INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS
	Geographic Sales Regions
	We currently sell and distribute our products four geographic regions: North Asia, Greater China, South Asia/Pacific, Europe, Middle East, and Americas. The following table sets forth the revenue for each of the geographic regions for the years ended July 31, 2014 and 2013:
			Years Ended July 31,
			2014					2013
	Americas		$	1,594,361	66.36	%		$	2,058,531	72.02	%
	Europe			5,000	0.2				-	-
	Greater China			253,265	10.54				226,424	7.92
	Middle East			293	0.01				-	-
	North Asia			35,976	1.5				467,371	16.35
	South Asia/Pacific			513,874	21.39				105,874	3.7
			$	2,402,769	100	%		$	2,858,200	100	%
	The table below lists our equipment, net, by geographic area for the years ended July 31, 2014 and 2013:
			Years Ended July 31,
			2014					2013
	Americas		$	16,355	100	%		$	22,336	100	%
	Europe			-	-				-	-
	Greater China			-	-				-	-
	Middle East			-	-				-	-
	North Asia			-	-				-	-
	South Asia/Pacific			-	-				-	-
			$	16,355	100	%		$	22,336	100	%
	The table below lists revenue generated by each of the Company's product lines during the years ended July 31, 2014 and 2013:
		Years Ended July 31,
		2014					2013
	Product Sales		$	2,393,071	99.6	%		$	2,847,652	99.63	%
	NBA Services			9,698	0.4				10,548	0.37
	Educational Services			-	-				-	-
			$	2,402,769	100	%		$	2,858,200	100	%
	Significant Customers
	There is currently one customer that makes up 38% and 46% of total sales as of July 31, 2014 and 2013, respectively.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Jul. 31, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 15 – SUBSEQUENT EVENTS
	On August 5, 2014, the Company amended the License Agreement entered into on November 18, 2013, between the Company and Genesar to (1) remove the clause triggering royalty payments to begin after 4,000 boxes have been sold, and instead beginning royalty payments on the 20th of each month following the end of each of the Company's fiscal quarters, (2) adding a minimum royalty payment of $25,000 per year,(3) adjust the royalty fee to $5/box of 30 sachets of GenEpic sold by the Company from $4/box, and (4) restructuring the advance of $140,000, to a one-time license payment, which would no longer be offset against future royalty fees incurred on products sold.
	On August 25, 2014, the Company issued a fourth put notice for 595,134 shares of common stock as part of the Equity Purchase Agreement in footnote 12 and issued an additional 4,866 shares related to the third put notice as required by the true-up provision in Equity Purchase Agreement, receiving net funds of $31,623.04 from Southridge, and subsequently issuing Southridge an additional 7,554 shares of common stock as true-up shares related to the fourth put notice on September 16, 2014.
	On September 24, 2014, Asher converted $15,000 of principal related to the January 14, 2014, convertible note into 586,658 shares of the Company's common stock at $0.0257 per share.
	On October 2, 2014, Asher converted an additional $15,000 of principal related to the January 14, 2014, convertible note into 810,811 shares of the Company's common stock at $0.0185 per share.
	On October 9, 2014, Asher converted an additional $12,000 of principal related to the January 14, 2014, convertible note, into 869,565 shares of the Company's common stock at $0.0138 per share. The remaining principal balance due after the conversions was $36,500.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jul. 31, 2014
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the economic environment, which management believes to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.
Accounting Basis	'
	Accounting Basis
	The Company's financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States. The Company has elected a July 31 fiscal year end.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Cash and cash equivalents include all cash balances and highly liquid investments with an original maturity of three months or less. As of July 31, 2014 and 2013, the Company's cash balances were within the FDIC insurance coverage limits.
Revenue Recognition	'
	Revenue Recognition
	Our revenue is derived from the service revenue from Live Blood Analysis, sale of retail products, and revenue derived from educational services.
	The Company's revenue recognition policy is in accordance with the requirements of Accounting Standards Codification ("ASC") 605, Revenue Recognition, and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. In this case, revenues are recognized upon notification that customer receipt has occurred. The Company accrues an estimated amount for sales returns and allowances related to defective or returned products at the time of sale based on its ability to estimate sales returns and allowances using historical information. As of July 31, 2014 and 2013, the Company calculated the amount to be less than 1% of sales so no allowance was accrued in either year. Shipping and handling fees and related freight costs and supplies associated with shipping products to customers are included as a component of cost of sales. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue.
	The Company also recognizes revenues from the distribution of its product through trade partners. Related revenues consist of product costs, distribution fees, testing and labeling costs, as well as any associated administrative fees. The Company recognizes these revenues after the product has been shipped from the outsource manufacturer to the trade partner. The Company has contractual obligation to pay the outsource manufacturers, and as a principal in these arrangements the Company includes the total product price as revenue in accordance with applicable accounting guidance. The Company has separately negotiated contractual relationships with its trade partners, and under contracts with these trade partners the Company assumes the credit risk of product produced by the outsource manufacturer and dispensed to the trade partner.
	Unearned Revenues consist of cash received in advance for products to be delivered at a future date. The Company records the payments received as a liability until the products are delivered. The Company recorded unearned revenue of $338,263 and $58,418 as of July 31, 2014 and 2013, respectively.
Cost of Sales	'
	Cost of Sales
	The Company includes product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, insurance on inventory, production-related depreciation expense and product license agreement expense in cost of sales.
Advertising Costs	'
	Advertising Costs
	The Company classifies expenses for advertising as general and administrative expenses. The Company incurred advertising costs of $156,708 and $50,284 during the years ended July 31, 2014 and 2013, respectively.
Accounts Receivable	'
	Accounts Receivable
	Receivables from the sale of goods and services are stated at net realizable value, do not bear interest and do not generally require collateral. The Company adjusts credit limits based upon payment history and the customer's current creditworthiness. The Company maintains an allowance for doubtful accounts based upon a variety of factors. The Company reviews all open accounts and provides specific reserves for customer collection issues when it believes the loss is probable, considering such factors as the length of time receivables are past due, the financial condition of the customer, and historical experience. The Company also records a reserve for all customers, excluding those that have been specifically reserved for, based upon evaluation of historical losses. The Company recorded an allowance for doubtful accounts of $106,617 and $112,389 as of July 31, 2014 and 2013, respectively.
Inventories	'
	Inventories
	Inventories are stated at the lower of cost or market. The cost for inventories is determined using the first-in, first-out method on the weighted average basis. The cost includes all expenditures incurred in bringing the goods to the point of sale and putting them in a salable condition. In assessing the ultimate realization of inventories, the Company makes judgments as to future demand requirements compared to current or committed inventory levels. The Company estimates the demand requirements based on market conditions, forecasts prepared by its customers, sales contracts and orders in hand. In addition, the Company estimates net realizable value based on intended use, current market value and inventory aging analyses. The Company writes down inventories for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventories and their estimated market value based upon assumptions about future demand and market conditions. As of July 31 inventories consisted of the following:
		July 31,		July 31,
		2014		2013
	Raw materials	$	41,056	$	35,713
	Finished goods		230,885		240,764
	Subtotal		271,941		276,477
	Reserve for obsolescence		-		-
	Total	$	271,941	$	276,477
Concentration of Credit Risk	'
	Concentration of Credit Risk
	Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash, accounts receivable, accounts payable, lines of credit, and notes payable. Due to short-term maturities, the carrying amount of these instruments approximates fair value. Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company occasionally maintains amounts on deposit with a financial institution that are in excess of the federally insured limit of $250,000. The risk is managed by maintaining all deposits in high quality financial institutions. The Company had $0 of cash balances in excess of federally insured limits at July 31, 2014 and 2013.
Property and Equipment	'
	Property and Equipment
	Property and equipment are recorded at cost less accumulated depreciation. Depreciation and amortization are calculated using the straight-line method over the expected useful life of the asset, after the asset is placed in service. Assets recorded under leasehold improvements are amortized using the straight-line method over the lesser of their useful lives or the related lease term. The Company uses the following useful lives for its major classifications of property and equipment:
	Description	Useful Lives
	Furniture & Fixtures	7 years
	Office Furniture	5 years
	Equipment & Machinery	5-7 years
	Leasehold Improvements	15 years
	The Company periodically evaluates the carrying value of long-lived assets to be held and used in accordance with ASC Topic 360. ASC Topic 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the asset's carrying amount. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair market values are reduced for the cost of disposal. For the years ended July 31, 2014 and 2013, the Company recorded no impairment losses.
Research and Development Costs	'
	Research and Development Costs
	The Company expenses the costs of the development of its nutritional products during the period incurred. The Company incurred research and development expenses of $32,233 and $44,706 during the years ended July 31, 2014 and 2013, respectively.
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company follows the provisions of ASC 718 which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. The Company uses the Black-Scholes option valuation model for determining the fair value of stock based compensation. Option pricing models require the input of highly subjective assumptions, including the expected price volatility. Changes in these assumptions can materially affect the fair value estimate.
	The Company records the stock-based compensation awards issued to non-employees and other external entities for goods and services at either the fair market value of the goods received or services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines pertaining to when the service is complete or a performance commitment date is reached, whichever is earlier.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws expected to be in effect when the differences are expected to be settled or realized. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax assets are reviewed for recoverability, and the Company records a valuation allowance to reduce its deferred income tax assets when it is more likely than not that all or some portion of the deferred income tax assets will not be realized.
	The Company recognizes the effect of tax positions only if those positions are more likely than not of being sustained. Recognized tax positions are measured at the largest amount that is greater than 50 percent likely to be realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Estimated interest and penalties related to underpayment of income taxes are recorded as a component of the tax provision in the statement of operations.
Loss per Share	'
	Loss per Share
	Basic loss per share ("EPS") is computed by dividing net loss (the numerator) by the weighted-average number of common shares outstanding for the period (the denominator). Diluted EPS is computed by dividing net loss by the weighted-average number of common shares and potential common shares outstanding (if dilutive) during each period. Potential common shares include common shares to be issued related to convertible debentures and stock pending issue under the ratchet provision.
	As the Company has incurred losses for the years ended July 31, 2014 and 2013, the potentially dilutive shares are anti-dilutive and are thus not added into the loss per share calculations.
Significant Concentrations	'
	Significant Concentrations
	There is currently one customer that makes up 38% and 46% of total sales as of July 31, 2014 and 2013, respectively. The loss of this customer would have a material adverse effect on the Company's financial condition and results of operation. There are currently five and three vendors that make up 70% and 81% of total purchases as of July 31, 2014 and 2013, respectively.
Sales Tax Collected From Customers	'
	Sales Tax Collected From Customers
	As a part of the Company's normal course of business, sales taxes are collected from customers. Such taxes collected are remitted, in a timely manner, to the appropriate governmental tax authority on behalf of the customer. The Company's policy is to present revenue and costs, net of value added and sales taxes.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	ASC 820, "Fair Value Measurements and Disclosures" requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 - Quoted prices in active markets for identical assets or liabilities;
	Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and
	Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing.
	The carrying amounts of the Company's financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments.
	The Company's Level 2 financial liabilities consist of the derivative liability of the Company's convertible promissory notes issued to investors. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a multinomial lattice model which incorporates transaction details such as Company stock price, contractual terms, default provisions, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In August 2014, the FASB amended Accounting Standards Update (ASU) ASU 205-40, Presentation of Financial Statements – Going Concern an entity's management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). Although public companies are required to apply the new guidance to all reporting periods beginning on or after December 15, 2016 (all other entities in the following year), the Company has adopted the new standard.
	In September 2014, the FASB issued Accounting Standards Update (ASU) ASU 606 which superseded and replaced ASC 605-25, Revenue Recognition: Multiple-Element Arrangements, and most of ASC 985-605, Software: Revenue Recognition, which applies to all software and SaaS arrangements. Although public companies are required to apply the new guidance to all reporting periods beginning on or after December 15, 2016 (all other entities in the following year), the Company has not yet adopted the new standard.
Going Concern	'
	Going Concern
	The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has generally had net losses after consideration of income taxes. Further, the Company has negative working capital and insufficient cash flows from operation as of July 31, 2014, and does not have the requisite liquidity to pay its current obligations. These factors, among others, raise substantial doubt about its ability to continue as a going concern. Management will seek to increase revenues and reduce costs, while raising capital through the sale of its stock. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jul. 31, 2014
Accounting Policies [Abstract]	'
Schedule of inventories	'
		July 31,		July 31,
		2014		2013
	Raw materials	$	41,056	$	35,713
	Finished goods		230,885		240,764
	Subtotal		271,941		276,477
	Reserve for obsolescence		-		-
	Total	$	271,941	$	276,477
Schedule of useful lives of property and equipment	'
	Description	Useful Lives
	Furniture & Fixtures	7 years
	Office Furniture	5 years
	Equipment & Machinery	5-7 years
	Leasehold Improvements	15 years

PROVISION_FOR_INCOME_TAXES_Tab

PROVISION FOR INCOME TAXES (Tables)	12 Months Ended
	Jul. 31, 2014
Income Tax Disclosure [Abstract]	'
Schedule of provision for income taxes	'
		July 31,			July 31,
		2014			2013
	Federal income tax expense	$	-		$	-
	State income tax expense		-			-
	Less change in valuation allowance		-			-
	Net income tax expense	$	-		$	-
Schedule of reconciliation of income taxes	'
		2014			2013
	Federal income taxes at 34%	$	(738,562	)	$	(58,328	)
	State income tax, net of federal benefit		(71,684	)		(5,661	)
	Change in net operating loss		-			18,385
	Tax effect on non-deductible expenses and credits		1,844			701
	Changes in valuation allowance		808,402			44,903
		$	-		$	-
Schedule of deferred tax assets and liabilities	'
		July 31,			July 31,
		2014			2013
	Deferred tax asset attributable to:
	Net operating loss carryover	$	1,027,802		$	242,339
	Allowance for doubtful accounts		39,768			42,914
	Depreciation		2,776			9,302
	Less, valuation allowance		(1,070,346	)		(294,555	)
	Net deferred tax asset	$	-		$	-
	Deferred tax liability attributable to:
	Depreciation	$	-		$	-
	Net deferred tax liabilities	$	-		$	-

LEASES_Tables

LEASES (Tables)	12 Months Ended
	Jul. 31, 2014
Leases [Abstract]	'
Schedule of minimum lease payments required under the operating leases	'
	Year Ended July 31,	Amount
	2015	$	16,875
	2016		-
	2017		-
	2018		-
	Thereafter		-
	Total lease obligations	$	16,875

EQUIPMENT_Tables

EQUIPMENT (Tables)	12 Months Ended
	Jul. 31, 2014
Property, Plant and Equipment [Abstract]	'
Schedule of property and equipment	'
		July 31,			July 31,
		2014			2013
	Furniture & Fixtures	$	11,860		$	11,860
	Office Furniture		28,932			28,932
	Equipment & Machinery		47,002			45,541
	Accumulated Depreciation		(71,439	)		(63,997	)
	Net Book Value	$	16,355		$	22,336

LINES_OF_CREDIT_AND_LOAN_PAYAB1

LINES OF CREDIT AND LOAN PAYABLE (Tables)	12 Months Ended
	Jul. 31, 2014
Lines Of Credit And Loan Payable [Abstract]	'
Schedule of loan payable	'
		July 31,			July 31,
		2014			2013
	$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.		$	208,901	$	-
	$50,000 face value, issued on December 9, 2013, with no interest rate, matured and was paid in full on May 31, 2014.			-		-
	Total Loan payable			208,901		-
	Less current portion			51,071		-
	Loan payable, long-term		$	157,830	$	-

CONVERTIBLE_NOTES_PAYABLE_AND_1

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Tables)	12 Months Ended
	Jul. 31, 2014
Convertible Notes Payable And Loan Payable [Abstract]	'
Schedule of convertible notes payable	'
		July 31,		July 31,
		2014		2013
	$250,000 face value, issued on September 27, 2013, interest rate of 10%, matures on September 27, 2015.	$	250,000	$	-
	$125,000 face value, issued on October 18, 2013, interest rate of 10%, matures on October 18, 2015.		125,000		-
	$150,000 face value, issued on November 22, 2013, interest rate of 10%, matures on November 22, 2015.		150,000		-
	$78,500 face value, issued on January 14, 2014, interest rate of 8%, matures on October 14, 2014, net of unamortized discount of $48,741 and $0 as of July 31, 2014 and July 31, 2013.		29,759		-
	$53,000 face value, issued on March 19, 2014, interest rate of 8%, matures on December 26, 2014, net of unamortized discount of $39,087 and $0 as of July 31, 2014 and July 31, 2013.		13,913		-
	$63,000 face value, issued on May 15, 2014, interest rate of 8%, matures on February 2, 2015, net of unamortized discount of $47,673 and $0 as of January 31, 2014 and July 31, 2013.		15,327		-
	Total convertible notes payable – non-related parties		583,999		-
	Less current portion		58,999		-
	Convertible notes payable, long-term	$	525,000	$	-

DERIVATIVE_LIABILITY_Tables

DERIVATIVE LIABILITY (Tables)	12 Months Ended
	Jul. 31, 2014
Derivative Liability [Abstract]	'
Schedule of financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs	'
	Balance at July 31, 2013		$	-
	New Derivative Liability			192,365
	Total (gains)losses included in earnings			(14,458	)
	Issuances			-
	Balance at July 31, 2014		$	177,907
Schedule of assumptions used to calculate the fair value of the derivative liability	'
		July 31,
		2014
	Expected term in years		.21-51 years
	Risk-free interest rates		0.05-0.12	%
	Volatility		121-.157	%
	Dividend yield		0	%

INDUSTRY_SEGMENT_GEOGRAPHIC_IN1

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Tables)	12 Months Ended
	Jul. 31, 2014
Segment Reporting [Abstract]	'
Schedule of revenue for each of geographic regions	'
			Years Ended July 31,
			2014					2013
	Americas		$	1,594,361	66.36	%		$	2,058,531	72.02	%
	Europe			5,000	0.2				-	-
	Greater China			253,265	10.54				226,424	7.92
	Middle East			293	0.01				-	-
	North Asia			35,976	1.5				467,371	16.35
	South Asia/Pacific			513,874	21.39				105,874	3.7
			$	2,402,769	100	%		$	2,858,200	100	%
Schedule of equipment, net, by geographic area	'
			Years Ended July 31,
			2014					2013
	Americas		$	16,355	100	%		$	22,336	100	%
	Europe			-	-				-	-
	Greater China			-	-				-	-
	Middle East			-	-				-	-
	North Asia			-	-				-	-
	South Asia/Pacific			-	-				-	-
			$	16,355	100	%		$	22,336	100	%
Schedule of revenue generated by each of product lines	'
		Years Ended July 31,
		2014					2013
	Product Sales		$	2,393,071	99.6	%		$	2,847,652	99.63	%
	NBA Services			9,698	0.4				10,548	0.37
	Educational Services			-	-				-	-
			$	2,402,769	100	%		$	2,858,200	100	%

NATURE_OF_OPERATIONS_Detail_Te

NATURE OF OPERATIONS (Detail Textuals)	12 Months Ended		0 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	Sep. 13, 2013	Sep. 13, 2013
	Country		Reverse Acquisition And Recapitalization	Reverse Acquisition And Recapitalization
			Share Exchange Agreement	Share Exchange Agreement
			Buka Ventures Inc	Health Education Corporation
Organization And Basis Of Presentation [Line Items]	'	'	'	'
Number of countries where company sells its products directly to public	16	'	'	'
Number of shares cancelled	'	'	25,000,000	'
Number of common shares issued	51,151,766	25,005,544	46,500,000	'
Number of common shares outstanding	51,151,766	25,005,544	46,500,000	'
Number of common stock issued in exchange with Nutranomics	'	'	25,005,544	'
Number of common stock shares received from Nutranomics	'	'	'	8,994,800

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Accounting Policies [Abstract]	'	'
Raw materials	$41,056	$35,713
Finished goods	230,885	240,764
Subtotal	271,941	276,477
Reserve for obsolescence	'	'
Total	$271,941	$276,477

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	12 Months Ended
	Jul. 31, 2014
Furniture & Fixtures	'
Property, Plant and Equipment [Line Items]	'
Useful Lives	'7 years
Office Furniture	'
Property, Plant and Equipment [Line Items]	'
Useful Lives	'5 years
Equipment & Machinery	'
Property, Plant and Equipment [Line Items]	'
Useful Lives	'5-7 years
Leasehold Improvements	'
Property, Plant and Equipment [Line Items]	'
Useful Lives	'15 years

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Summary Of Significant Accounting Policies [Line Items]	'	'
Unearned revenue	$338,263	$58,418
Advertising costs	156,708	50,284
Allowance for doubtful accounts	106,617	112,389
Cash balances in excess of federally insured limits	0	0
Research and development	$32,233	$44,706
Valuation model for determining the fair value of stock based compensation	'Black-Scholes option	'
Customer	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Number of customers	5	5
Concentration risk, percentage	38.00%	46.00%
Vendor	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Number of vendor	3	3
Concentration risk, percentage	70.00%	81.00%

PROVISION_FOR_INCOME_TAXES_Det

PROVISION FOR INCOME TAXES (Details) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Federal income tax expense	'	'
State income tax expense	'	'
Less change in valuation allowance	'	'
Net income tax expense	'	'

PROVISION_FOR_INCOME_TAXES_Det1

PROVISION FOR INCOME TAXES (Details 1) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Federal income taxes at 34%	($738,562)	($58,328)
State income tax, net of federal benefit	-71,684	-5,661
Change in net operating loss	'	18,385
Tax effect on non-deductible expenses and credits	1,844	701
Changes in valuation allowance	808,402	44,903
Income Tax Expense (Benefit)	'	'

PROVISION_FOR_INCOME_TAXES_Det2

PROVISION FOR INCOME TAXES (Details 2) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Deferred tax asset attributable to:	'	'
Net operating loss carryover	$1,027,802	$242,339
Allowance for doubtful accounts	39,768	42,914
Depreciation	2,776	9,302
Less, valuation allowance	-1,070,346	-294,555
Net deferred tax asset	'	'
Deferred tax liability attributable to:	'	'
Depreciation	'	'
Net deferred tax liabilities	'	'

PROVISION_FOR_INCOME_TAXES_Det3

PROVISION FOR INCOME TAXES (Detail Textuals) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Federal statutory income tax rate	34.00%	'
Net deferred tax asset	'	'
Increase in Deferred tax asset, Valuation allowance	775,791	'
Deferred tax asset, Valuation allowance	1,070,346	294,555
Net operating loss carryforward	$2,812,000	'

ADVANCES_ON_ROYALTIES_Detail_T

ADVANCES ON ROYALTIES (Detail Textuals) (License Agreement, USD $)	0 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended
	Dec. 01, 2013	Nov. 18, 2013	Dec. 01, 2013	Nov. 18, 2013	Jul. 31, 2014	Nov. 18, 2013	Aug. 05, 2014	Nov. 18, 2013
	GenEpic	GenEpic	Genesar	Genesar	Genesar	Genesar	Genesar	Genesar
	Subsequent Event	Subsequent Event				GenEpic	GenEpic	GenEpic
						Box	Subsequent Event	Subsequent Event
						Sachet	Sachet	Sachet
							Box	Box
Advances On Royalties [Line Items]	'	'	'	'	'	'	'	'
Restricted common shares entitled to receive	'	100,000	'	100,000	'	'	'	'
Value of restricted common shares entitled to receive	'	$60,900	'	$60,900	'	'	'	'
Royalty fees per box	'	4	'	4	'	'	5	'
Number of sachets in a box	'	'	'	'	'	30	30	30
Number of boxes after which royalty fee per box paid	'	'	'	'	'	4,000	4,000	4,000
Agreement description	'	'The License Agreement has an initial term of 36 months, and will automatically renew for another 36-month term unless terminated by providing 90 days written notice to the other party prior to the end of the term.	'	'The License Agreement has an initial term of 36 months, and will automatically renew for another 36-month term unless terminated by providing 90 days written notice to the other party prior to the end of the term.	'	'	'	'
Prepayment on royalty fees	'	'	'	'	200,000	'	140,000	'
Advances on royalty fees	200,000	'	200,000	'	'	'	'	'
Royalty fees paid	'	'	'	'	140,000	'	'	'
Minimum royalty payment	'	'	'	'	'	'	25,000	'
Remaining balance in advances on royalties	'	'	'	'	'	'	$0	'

LEASES_Details

LEASES (Details) (USD $)	Jul. 31, 2014
Lease obligations	'
2015	$16,875
2016	'
2017	'
2018	'
Thereafter	'
Total lease obligations	$16,875

LEASES_Detail_Textuals

LEASES (Detail Textuals) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
	Lease
	sqft
Leases [Line Items]	'	'
Expiry date of lease	31-Dec-14	'
Rent expenses	$50,115	$46,140
Area of office (in square foot)	3,000	'
Area of subleased property (in Square feet)	1,500	'
Number of terminated lease	2	'
Date of termination of first subleased property	'September 2013	'
Date of termination of second subleased property	'October 2013	'
Rent received	1,850	12,500
Machinery and equipment	'	'
Leases [Line Items]	'	'
Expiry date of lease	15-Jul-13	'
Rent expenses	$4,346	$3,717

EQUIPMENT_Details

EQUIPMENT (Details) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Accumulated Depreciation	($71,439)	($63,997)
Net Book Value	16,355	22,336
Furniture & Fixtures	'	'
Property, Plant and Equipment [Line Items]	'	'
Gross Book Value	11,860	11,860
Office Furniture	'	'
Property, Plant and Equipment [Line Items]	'	'
Gross Book Value	28,932	28,932
Equipment & Machinery	'	'
Property, Plant and Equipment [Line Items]	'	'
Gross Book Value	$47,002	$45,541

EQUIPMENT_Detail_Textuals

EQUIPMENT (Detail Textuals) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Property, Plant and Equipment [Abstract]	'	'
Depreciation	$7,442	$8,319

RELATED_PARTY_NOTES_PAYABLE_De

RELATED PARTY NOTES PAYABLE (Detail Textuals) (USD $)	12 Months Ended		1 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	Jan. 31, 2012
			Notes payable
			Officer
Debt Instrument [Line Items]	'	'	'
Maturity period of note payable	'	'	'2 years
Percentage of interest rate on note payable	'	'	0.00%
Percentage of imputed interest rate on note payable	'	'	8.00%
Note payable	'	'	$150,000
Maturity date of note payable	'	'	31-Dec-14
Royalty payments	38,392	1,063	'
Amount of principal in related party notes payable	$36,608	$75,000	'

RELATED_PARTY_PAYABLE_Detail_T

RELATED PARTY PAYABLE (Detail Textuals) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Related Party Transaction [Line Items]	'	'
Proceeds from related party payable	'	$16,208
Due to related parties	21,083	24,514
Officer	'	'
Related Party Transaction [Line Items]	'	'
Proceeds from related party payable	0	16,208
Repayment made by the company	$3,431	$7,381

LINES_OF_CREDIT_AND_LOAN_PAYAB2

LINES OF CREDIT AND LOAN PAYABLE (Details) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Debt Instrument [Line Items]	'	'
Total Loan payable	$208,901	'
Less current portion	51,071	'
Loan payable, long-term	157,830	'
$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.	'	'
Debt Instrument [Line Items]	'	'
Total Loan payable	208,901	'
$50,000 face value, issued on December 9, 2013, with no interest rate, matured and was paid in full on May 31, 2014	'	'
Debt Instrument [Line Items]	'	'
Total Loan payable	'	'

LINES_OF_CREDIT_AND_LOAN_PAYAB3

LINES OF CREDIT AND LOAN PAYABLE (Detail Textuals) (USD $)	Jul. 31, 2014	Jul. 31, 2013	Dec. 09, 2013	Aug. 28, 2013	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 1998
			Promissory Note	Loans Payable	Loans Payable	Loans Payable	Line of Credit	Line of Credit	Zions Bank
			Equity Purchase Agreement						Line of Credit
			Southridge Partners II, LP ("Southridge")
Line of Credit Facility [Line Items]	'	'	'	'	'	'	'	'	'
Line of credit facility, amount	$250,000	'	'	$250,000	'	'	'	'	$40,000
Line of credit facility, repayment period	'	'	'	'5 years	'	'	'	'	'
Line of credit, initial interest rate	'	'	'	'	'	'	'	'	5.25%
Debt instrument basis spread on variable rate	'	'	'	1.96%	'	'	'	'	'
Face amount of note payable	'	'	50,000	250,000	'	'	'	'	'
Maturity date of note payable	'	'	31-May-14	1-Sep-18	'	'	'	'	'
Percentage of interest rate on note payable	'	'	0.00%	5.21%	'	'	'	'	'
Note payable, minimum monthly payments	'	'	'	4,745	'	'	'	'	'
Note payable, frequency of minimum monthly payments	'	'	'	'monthly	'	'	'	'	'
Note payable	208,901	'	'	'	208,901	'	208,901	244,000	'
Loan payable paid in principal payment	'	'	'	'	41,099	'	'	'	'
Note payable, allowable portion to be absorbed	'	'	'	50,000	'	'	'	'	'
Lines of credit, current	33,098	261,911	'	'	'	'	'	'	'
Note payable, issuance cost	'	'	'	$4,037	'	'	'	'	'

CONVERTIBLE_NOTES_PAYABLE_AND_2

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Details) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Debt Instrument [Line Items]	'	'
Convertible notes payable-current portion	$58,999	'
Convertible notes payable, long-term	525,000	'
Convertible notes payable	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	583,999	'
Convertible notes payable-current portion	58,999	'
Convertible notes payable, long-term	525,000	'
Convertible notes payable | Convertible notes payable matures on September 27, 2015	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	250,000	'
Convertible notes payable | Convertible notes payable matures on October 18, 2015	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	125,000	'
Convertible notes payable | Convertible notes payable matures on November 22, 2015	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	150,000	'
Convertible notes payable | Convertible notes payable matures on October 14, 2014	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	29,759	'
Convertible notes payable | Convertible notes payable matures on December 26, 2014	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	13,913	'
Convertible notes payable | Convertible notes payable matures on February 2, 2015	'	'
Debt Instrument [Line Items]	'	'
Total convertible notes payable - non-related parties	$15,327	'

CONVERTIBLE_NOTES_PAYABLE_AND_3

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals) (Convertible notes payable, Unrelated party, USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
	Day
Convertible notes payable matures on September 27, 2015	'	'
Debt Instrument [Line Items]	'	'
Note payable	$250,000	'
Maturity date of convertible note	17-Sep-15	'
Interest rate of convertible note	10.00%	'
Floor price of convertible note	$0.01	'
Number of threshold trading days	5	'
Convertible notes payable matures on October 18, 2015	'	'
Debt Instrument [Line Items]	'	'
Note payable	125,000	'
Maturity date of convertible note	18-Oct-15	'
Interest rate of convertible note	10.00%	'
Floor price of convertible note	$0.01	'
Number of threshold trading days	5	'
Convertible notes payable matures on November 22, 2015	'	'
Debt Instrument [Line Items]	'	'
Note payable	150,000	'
Maturity date of convertible note	22-Nov-15	'
Interest rate of convertible note	10.00%	'
Floor price of convertible note	$0.01	'
Number of threshold trading days	5	'
Convertible notes payable matures on October 14, 2014	'	'
Debt Instrument [Line Items]	'	'
Note payable	78,500	'
Maturity date of convertible note	14-Oct-14	'
Interest rate of convertible note	8.00%	'
Floor price of convertible note	$0.00	'
Unamortized discount	48,741	0
Number of threshold trading days	10	'
Threshold consecutive days	'3 days	'
Convertible notes payable matures on December 26, 2014	'	'
Debt Instrument [Line Items]	'	'
Note payable	53,000	'
Maturity date of convertible note	26-Dec-14	'
Interest rate of convertible note	8.00%	'
Unamortized discount	39,087	0
Number of threshold trading days	3	'
Threshold consecutive days	'3 days	'
Convertible notes payable matures on February 2, 2015	'	'
Debt Instrument [Line Items]	'	'
Note payable	63,000	'
Maturity date of convertible note	2-Feb-15	'
Interest rate of convertible note	8.00%	'
Floor price of convertible note	$0.00	'
Unamortized discount	$47,673	$0
Number of threshold trading days	3	'
Threshold consecutive days	'3 days	'

CONVERTIBLE_NOTES_PAYABLE_AND_4

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 1) (USD $)	12 Months Ended		12 Months Ended	0 Months Ended		1 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2014	Jan. 14, 2014	15-May-14	Mar. 19, 2014
			Convertible notes payable	Convertible notes payable	Convertible notes payable	Convertible notes payable
				Asher Enterprises, Inc. ("Asher")	KBM Worldwide, Inc. ("KBM")	KBM Worldwide, Inc. ("KBM")
Debt Instrument [Line Items]	'	'	'	'	'	'
Face amount of note payable	'	'	'	$78,500	$63,000	$53,000
Percentage of interest rate on note payable	'	'	'	8.00%	8.00%	8.00%
Percentage of common stock price to conversion price	'	'	'	58.00%	58.00%	58.00%
Price of the entity's common stock which would be required to be attained for the conversion	'	'	'	$0.00	$0.00	$0.00
Principal payments made during the period	'	'	'	58,600	42,500	24,487
Legal and accounting fees	'	'	'	19,900	17,500	6,898
Purchases of financial instrument classified as a derivative asset (liability)	192,365	'	'	87,968	56,591	47,806
Unamortized discount	'	'	'	78,500	56,591	49,010
Fair value of financial instrument classified as derivative asset (liability)	177,907	'	177,907	87,351	'	'
Gain on derivative liability	14,458	'	14,458	'	'	'
Amortization of debt discount	$47,396	'	$47,396	'	'	'

STOCK_TRANSACTIONS_Detail_Text

STOCK TRANSACTIONS (Detail Textuals) (USD $)	Jul. 31, 2014	Jul. 31, 2013
Stockholders' Equity Note [Abstract]	'	'
Common stock, shares authorized	750,000,000	750,000,000
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares issued	51,151,766	25,005,544
Common stock, shares outstanding	51,151,766	25,005,544

STOCK_TRANSACTIONS_Detail_Text1

STOCK TRANSACTIONS (Detail Textuals 1) (Equity Purchase Agreement, Southridge Partners II, LP ("Southridge"), USD $)	0 Months Ended
	Dec. 09, 2013
	Day
Stock Transactions [Line Items]	'
Maximum issued amount of common stock	$10,000,000
Term of agreement	'24 months
Put notice description	'The Company will deliver to Southridge, simultaneously with delivery of a Put Notice, a number of Shares equal to 125% of the Investment Amount divided by the closing price of the Company's common stock on the day preceding the Put Notice date (the "Estimated Put Shares").
Number of daily volume weighted average prices	3
Number of trading days	'10 days
Minimum percentage of common stock sold	9.99%
Equity purchase agreement, condition	'(i) 24 months from the effective date of a registration statement to be filed in connection therewith or (ii) the date on which Southridge has purchased shares of common stock pursuant to this agreement for an aggregate maximum purchase price of $10,000,000; such commitment is subject to certain conditions. The purchase price to be paid by Southridge will be 90% of the average of the lowest three (3) daily volume weighted average prices for the Company's common stock for the ten (10) trading days immediately following clearing of the Estimated Put Shares (defined below) (such purchase price the "Put Purchase Price") under the Equity Purchase Agreement.
Promissory Note	'
Stock Transactions [Line Items]	'
Note issued on agreement	$50,000
Interest paid on agreement	0.00%
Maturity date of note payable	31-May-14

STOCK_TRANSACTIONS_Detail_Text2

STOCK TRANSACTIONS (Detail Textuals 2) (USD $)	12 Months Ended		0 Months Ended	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	5-May-14	Jul. 31, 2014	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2014	Jul. 31, 2014
			Equity Purchase Agreement	Equity Purchase Agreement	Common Stock	Common Stock	Common Stock	Common Stock
			Southridge Partners II, LP ("Southridge")	Southridge Partners II, LP ("Southridge")			Equity Purchase Agreement	Employees and Non-Employees
Stock Transactions [Line Items]	'	'	'	'	'	'	'	'
Number of shares of Common Stock issued as share-based compensation	'	'	'	'	'	'	'	2,429,555
Value of shares of issued as share-based compensation	'	'	'	'	'	'	'	$807,852
Common stock issued for services (in shares)	'	'	6,500,000	1,500,000	2,429,555	27,800	'	716,667
Value of shares of issued	807,852	5,000	'	'	2,430	28	'	189,875
Number of shares of issued for cash	'	'	'	'	'	'	1,500,000	'
Value of shares of issued for cash	'	'	'	'	'	'	$93,412	'

DERIVATIVE_LIABILITY_Details

DERIVATIVE LIABILITY (Details) (USD $)	12 Months Ended
	Jul. 31, 2014
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]	'
Balance at July 31, 2013	'
New Derivative Liability	192,365
Total (gains) losses included in earnings	-14,458
Issuances	'
Balance at July 31, 2014	$177,907

DERIVATIVE_LIABILITY_Detail_1

DERIVATIVE LIABILITY (Detail 1)	12 Months Ended
	Jul. 31, 2014
Derivatives, Fair Value [Line Items]	'
Dividend yield	0.00%
Minimum	'
Derivatives, Fair Value [Line Items]	'
Expected term in years	'2 months 16 days
Risk-free interest rates	0.05%
Volatility	121.00%
Maximum	'
Derivatives, Fair Value [Line Items]	'
Expected term in years	'6 months 4 days
Risk-free interest rates	0.12%
Volatility	157.00%

DERIVATIVE_LIABILITY_Detail_Te

DERIVATIVE LIABILITY (Detail Textuals) (USD $)	Jul. 31, 2014
Derivative Liability [Abstract]	'
Fair value of financial instrument classified as derivative asset (liability)	$177,907

INDUSTRY_SEGMENT_GEOGRAPHIC_IN2

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Segment Reporting Information [Line Items]	'	'
Revenue	$2,402,769	$2,858,200
Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	2,402,769	2,858,200
Concentration risk, percentage	100.00%	100.00%
Americas | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	1,594,361	2,058,531
Concentration risk, percentage	66.36%	72.02%
Europe | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	5,000	'
Concentration risk, percentage	0.20%	'
North Asia | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	35,976	467,371
Concentration risk, percentage	1.50%	16.35%
Greater China | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	253,265	226,424
Concentration risk, percentage	10.54%	7.92%
Middle East | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	293	'
Concentration risk, percentage	0.01%	'
South Asia/Pacific | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	$513,874	$105,874
Concentration risk, percentage	21.39%	3.70%

INDUSTRY_SEGMENT_GEOGRAPHIC_IN3

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details 1) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Segment Reporting Information [Line Items]	'	'
Equipment	$16,355	$22,336
Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	16,355	22,336
Concentration risk, percentage	100.00%	100.00%
Americas | Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	16,355	22,336
Concentration risk, percentage	100.00%	100.00%
Europe | Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	'	'
Concentration risk, percentage	'	'
Greater China | Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	'	'
Concentration risk, percentage	'	'
Middle East | Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	'	'
Concentration risk, percentage	'	'
North Asia | Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	'	'
Concentration risk, percentage	'	'
South Asia/Pacific | Equipment	'	'
Segment Reporting Information [Line Items]	'	'
Equipment	'	'
Concentration risk, percentage	'	'

INDUSTRY_SEGMENT_GEOGRAPHIC_IN4

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details 2) (USD $)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
Segment Reporting Information [Line Items]	'	'
Revenue	$2,402,769	$2,858,200
Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	2,402,769	2,858,200
Concentration risk, percentage	100.00%	100.00%
Product Sales | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	2,393,071	2,847,652
Concentration risk, percentage	99.60%	99.63%
NBA Services | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	9,698	10,548
Concentration risk, percentage	0.40%	0.37%
Educational Services | Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Revenue	'	'
Concentration risk, percentage	'	'

INDUSTRY_SEGMENT_GEOGRAPHIC_IN5

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Detail Textuals)	12 Months Ended
	Jul. 31, 2014	Jul. 31, 2013
	Customer	Customer
Segment Reporting Information [Line Items]	'	'
Number of geographic regions	4	'
Customer Concentration Risk	'	'
Segment Reporting Information [Line Items]	'	'
Number of customers	5	5
Percentage of total sales by single customer	38.00%	46.00%
Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Percentage of total sales by single customer	100.00%	100.00%
Revenue | Customer Concentration Risk	'	'
Segment Reporting Information [Line Items]	'	'
Number of customers	1	1
Percentage of total sales by single customer	38.00%	46.00%

SUBSEQUENT_EVENTS_Detail_Textu

SUBSEQUENT EVENTS (Detail Textuals) (USD $)

1 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

Nov. 18, 2013

Jul. 31, 2014

Nov. 18, 2013

Aug. 25, 2014

Sep. 16, 2014

Aug. 25, 2014

Nov. 18, 2013

Aug. 05, 2014

Nov. 18, 2013

Oct. 09, 2014

Oct. 02, 2014

Sep. 24, 2014

License Agreement

License Agreement

License Agreement

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Convertible notes payable

Convertible notes payable

Convertible notes payable

Genesar

Genesar

Genesar

Equity Purchase Agreement

Equity Purchase Agreement

Equity Purchase Agreement

License Agreement

License Agreement

License Agreement

Subsequent Event

Subsequent Event

Subsequent Event

GenEpic

Fourth Put Notice

Southridge Partners II, LP ("Southridge")

Southridge Partners II, LP ("Southridge")

GenEpic

Genesar

Genesar

Asher Enterprises, Inc. ("Asher")

Asher Enterprises, Inc. ("Asher")

Asher Enterprises, Inc. ("Asher")

Box

Fourth Put Notice

Third Put Notice

GenEpic

GenEpic

Sachet

Sachet

Sachet

Box

Box

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Royalty fees per box

4

'

'

'

'

'

4

5

'

'

'

'

Number of sachets in a box

'

'

30

'

'

'

'

30

30

'

'

'

Number of boxes after which royalty fee per box paid

'

'

4,000

'

'

'

'

4,000

4,000

'

'

'

Prepayment on royalty fees

'

$200,000

'

'

'

'

'

$140,000

'

'

'

'

Minimum royalty payment

'

'

'

'

'

'

'

25,000

'

'

'

'

Remaining balance in advances on royalties

'

'

'

'

'

'

'

0

'

'

'

'

Number of common stock

'

'

'

595,134

'

'

'

'

'

'

'

'

Number of additional common stock

'

'

'

'

7,554

4,866

'

'

'

'

'

'

Receiving net funds

'

'

'

'

'

31,623.04

'

'

'

'

'

'

Principal amount

'

'

'

'

'

'

'

'

'

12,000

15,000

15,000

Convertible note shares

'

'

'

'

'

'

'

'

'

869,565

810,811

586,658

Common stock convertible conversion per share

'

'

'

'

'

'

'

'

'

$0.01

$0.02

$0.03

Debt Instrument, remaining principal balance due

'

'

'

'

'

'

'

'

'

$36,500

'

'